Brazilian stock alert


Afternoon Alert: Brazil Pharma keeps sliding: down 21.9% in 6 days 16 January 2018 12:10 BRST


Brasil Pharma SA (SA:BPHA3) extended its slide on Tuesday, shedding an additional 15.0 centavos (or 4.8%) to trade at R$3.0. Trading volume was 1.8 times average so far today. The shares have fallen 84.0 centavos (or 21.9%) over the past six trading days vs. the Brazil Index 50 which has risen 0.8% in the same period.

SECTION 1: The past week

Current indications of bearish signals that support the trend in the unusual trading

1.1 At a glance

Weekly: Brazil Pharma continues significant downtrend January 15, 2018 18:00 BRST

Brasil Pharma SA (SA:BPHA3) has sunk 69.0 centavos (or 18.0%) in the past week to close at R$3.15. Compared with the Brazil Index 50 which rose 63.6 points (or 0.5%) in the week, this represented a relative price change of -18.4%. The volume was 1.5 times average trading per week of 498,375 shares. In the past week the market cap has slumped R$78 million.

1.2 5-day Recap

Brazil Pharma underperformed the Brazil index 50 in 5 out of 5 days.

DayHeadlineClose price [BRL]Price change %Relative change %Comment
MondayBrazil Pharma keeps sliding, down 18.0% in 5 days3.15-1.6-2.0
FridayBrazil Pharma falls in 4 out of last 5 days3.2-4.5-4.5
ThursdayBrazil Pharma continues significant downtrend; drops 3.7%3.35-3.7-5.2
WednesdayBrazil Pharma in its biggest weekly loss in 3 weeks3.48-4.7-3.8VI=3.3
TuesdayBrazil Pharma down 35% in less than 14 weeks3.65-4.9-4.6Steepest Fall

SECTION 2: Technical indicators


The negative 0.29 MACD (Moving Average Convergence Divergence) indicator suggests a bearish signal (12-day minus 26-day Exponential Moving Averages). Both the 12-day and the 26-day EMA are falling - another bearish signal. In the past week, the stock's MACD has been negative every day, a reinforcing bearish signal.

The stock has underperformed 97% of the Brazilian market over the past 6 months.

In the last one month the stock has hit a new 52-week low seven times and in the last three months ten times, pointing to a significant downtrend.

The price plummeted 17.8% in the last week and 22.7% in the last month.

The present value of BRL1,000 invested one year ago is R$536 [vs R$1,262 for the Brazil Index 50], for a capital loss of R$464. The total return to shareholders for 1 year is -46.4%.



The 1.0% premium to 12-month low of R$2.97 against the 70.7% discount to high of R$10.24 suggests the decline might be bottoming.

SECTION 3: Ranking

DescriptionValueRank In Market
MCap $US million105.5In Bottom Quartile
52-week Range (in R$)3.0-10.2
1-month Range (in R$)3.0-4.2
Williams %R-96.7Bullish
Bollinger Bands-0.1Bullish
Today's Volatility %4.4In Bottom Quartile
Price/MAP2000.59In Bottom 4%

Brasil Pharma SA (SA:BPHA3; SAO:BPHA3; BZ:BPHA3)


PermID: 5000807607